The Weill Department of Medicine (WDOM) has recruited Dr. Mark Reisman, a nationally and internationally recognized authority on structural heart disease, to the Division of Cardiology. Dr. Reisman will serve as Director of Structural Heart Disease at NYP/Weill Cornell Medicine and as Co-Director of Structural Heart Disease for NYP/Queens and NYP/Brooklyn Methodist Hospital.
Before joining the WDOM, Dr. Reisman served as an Attending Physician, Clinical Professor of Medicine, and was the David and Nancy Auth Endowed Chair in Cardiovascular Innovation at the University of Washington Medical Center (UW). While at UW, he was the Section Head of Interventional Cardiology and the Director of Structural Heart Services at the University of Washington’s Heart Institute.
Dr. Reisman earned his M.D. at the Sackler School of Medicine in New York City and served his residency training at St. Luke’s Roosevelt Hospital, where he completed a fellowship in cardiology. He completed an additional fellowship in interventional cardiology at the University of California San Diego Medical Center. Triple board certified in interventional cardiology, cardiovascular disease, and internal medicine, Dr. Reisman has been a principal investigator on more than 100 clinical trials and remains active on numerous trials that focus on structural heart disease and coronary artery disease.
In Dr. Reisman’s leadership positions at Weill Cornell Medicine, he will play a key role in implementing a structural heart disease strategic plan that encompasses business development and outreach, quality and clinical standardization, physician recruitment and clinical research trials, and cardiovascular innovation.